These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27766741)

  • 1. Development of lipopolysaccharide-mimicking peptides and their immunoprotectivity against Vibrio cholerae serogroup O1.
    Mohammad Pour Ghazi F; Gargari SL
    J Pept Sci; 2016 Nov; 22(11-12):682-688. PubMed ID: 27766741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides mimicking lipopolysaccharide as a potential vaccine candidates against
    Ghazi FMP; Gargari SLM
    Iran J Microbiol; 2017 Aug; 9(4):244-250. PubMed ID: 29238460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.
    Dharmasena MN; Krebs SJ; Taylor RK
    Microbiology (Reading); 2009 Jul; 155(Pt 7):2353-2364. PubMed ID: 19389772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
    Sayeed MA; Bufano MK; Xu P; Eckhoff G; Charles RC; Alam MM; Sultana T; Rashu MR; Berger A; Gonzalez-Escobedo G; Mandlik A; Bhuiyan TR; Leung DT; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
    PLoS Negl Trop Dis; 2015; 9(7):e0003881. PubMed ID: 26154421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine.
    Ghafouri E; Fadaie M; Amirkhani Z; Esmaeilifallah M; Rahimmanesh I; Hosseini N; Hejazi H; Khanahmad H
    Int Immunopharmacol; 2024 Jun; 134():112160. PubMed ID: 38710117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
    Kim D; Hong J; Choi Y; Han J; Kim S; Jo G; Yoon JY; Chae H; Yoon H; Lee C; Hong HJ
    J Microbiol Biotechnol; 2020 Nov; 30(11):1760-1768. PubMed ID: 32876069
    [No Abstract]   [Full Text] [Related]  

  • 7. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.
    Pérez JL; Acevedo R; Callicó A; Fernández Y; Cedré B; Año G; González L; Falero G; Talavera A; Pérez O; García L
    Vaccine; 2009 Jan; 27(2):205-12. PubMed ID: 18996426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
    Baranova DE; Willsey GG; Levinson KJ; Smith C; Wade J; Mantis NJ
    Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32589220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response.
    Falklind-Jerkérus S; Felici F; Cavalieri C; Lo Passo C; Garufi G; Pernice I; Islam MM; Qadri F; Weintraub A
    Microbes Infect; 2005 Dec; 7(15):1453-60. PubMed ID: 16046165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
    Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epitope analysis of an antibody specifically against Vibrio cholerae O1 Ogawa by phage library study.
    Cheng S; Lin Z; Liu X; Zheng W; Lu G; Tu Z; Zhang J; Zheng J; Yu X
    J Microbiol Methods; 2015 Oct; 117():22-7. PubMed ID: 26172085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh.
    Rahman A; Rashu R; Bhuiyan TR; Chowdhury F; Khan AI; Islam K; LaRocque RC; Ryan ET; Wrammert J; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2013 Oct; 20(10):1592-8. PubMed ID: 23945156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
    Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
    Uddin T; Aktar A; Xu P; Johnson RA; Rahman MA; Leung DT; Afrin S; Akter A; Alam MM; Rahman A; Chowdhury F; Khan AI; Bhuiyan TR; Bufano MK; Rashu R; Yu Y; Wu-Freeman Y; Harris JB; LaRocque RC; Charles RC; Kováč P; Calderwood SB; Ryan ET; Qadri F
    Am J Trop Med Hyg; 2014 May; 90(5):873-81. PubMed ID: 24686738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
    Haney DJ; Lock MD; Gurwith M; Simon JK; Ishioka G; Cohen MB; Kirkpatrick BD; Lyon CE; Chen WH; Sztein MB; Levine MM; Harris JB
    Vaccine; 2018 May; 36(20):2768-2773. PubMed ID: 29655627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET
    Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.
    Dharmasena MN; Jewell DA; Taylor RK
    J Biol Chem; 2007 Nov; 282(46):33805-33816. PubMed ID: 17881351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.